NCT01227759 is a Phase 2 clinical trial of Drug containing the active ingredient in Wounds, sponsored by Engelhard Arzneimittel GmbH & Co.KG.

Who is sponsoring NCT01227759?

NCT01227759 is sponsored by Engelhard Arzneimittel GmbH & Co.KG.

What drugs are being tested in NCT01227759?

Interventions in NCT01227759: Drug containing the active ingredient, Placebo.

What condition does NCT01227759 study?

NCT01227759 studies Wounds, Wound Healing.

Is NCT01227759 still recruiting?

NCT01227759 is currently completed. Last updated 25 October 2010.

Last reviewed 2010-10-25 · How we verify

NCT01227759

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Phase IIa, Single-center, Randomized, Observer-blind Trial With Intraindividual Comparison of Treated Versus Untreated to Assess the Wound Healing Efficacy of Topical Tyrosur® Gel

Completed Phase 2 Last updated 25 October 2010

What this trial tests

Phase 2 trial testing Drug containing the active ingredient in Wounds in 33 participants. Completed in 1 October 2010.

Timeline

1 September 2010

Primary endpoint
1 October 2010

1 October 2010

Quick facts

Lead sponsor	Engelhard Arzneimittel GmbH & Co.KG
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	single
Primary purpose	treatment
Enrollment	33
Start date	1 September 2010
Primary completion	1 October 2010
Estimated completion	1 October 2010

Drugs / interventions tested

Drug containing the active ingredient — full drug profile →
Placebo

Conditions studied

Wounds — all drugs for Wounds →
Wound Healing — all drugs for Wound Healing →

Sponsor

Engelhard Arzneimittel GmbH & Co.KG — full company profile →

Who can join

18 and older, any sex, with Wounds or Wound Healing. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Clinical assessment of the wound healing efficacy of verum compared to untreated using a score for wound healing rates
Time frame: 12 days

Sponsor's own description

This IIa study with intraindividual comparison of treated versus untreated to assess the wound healing efficacy of Tyrosur® Gel after experimental impairment of the skin using an abrasive wound healing model.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Wounds

Currently open trials in the same condition.

NCT06921707 — Pilot Trial for WounDx™ Clinical Decision Support Tool · NA · recruiting
NCT05608317 — A Clinical Investigation to Follow the Progress of Exuding Chronic Venous Leg Ulcers Using a Non-Bordered Foam Dressing · NA · recruiting

Other Engelhard Arzneimittel GmbH & Co.KG trials

Trials by the same sponsor.

NCT04703673 — Sinolpan® Pharmacy Non-interventional Study - Quality of Live · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01227759 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Engelhard Arzneimittel GmbH & Co.KG
Last refreshed: 25 October 2010

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01227759.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing